BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND NT5C2, ENSG00000076685, 22978, P49902, PNT5, NT5B, GMP, cN-II
99 results:

  • 1. Targeting the cGAS-STING Pathway Inhibits Peripheral T-cell lymphoma Progression and Enhances the Chemotherapeutic Efficacy.
    Lu X; Wang S; Hua X; Chen X; Zhan M; Hu Q; Cao L; Wu Z; Zhang W; Zuo X; Gui R; Fan L; Li J; Shi W; Jin H
    Adv Sci (Weinh); 2024 Mar; 11(10):e2306092. PubMed ID: 38145335
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human study.
    Zhang Y; Patel RP; Kim KH; Cho H; Jo JC; Jeong SH; Oh SY; Choi YS; Kim SH; Lee JH; Angelos M; Guruprasad P; Cohen I; Ugwuanyi O; Lee YG; Pajarillo R; Cho JH; Carturan A; Paruzzo L; Ghilardi G; Wang M; Kim S; Kim SM; Lee HJ; Park JH; Cui L; Lee TB; Hwang IS; Lee YH; Lee YJ; Porazzi P; Liu D; Lee Y; Kim JH; Lee JS; Yoon DH; Chung J; Ruella M
    Mol Cancer; 2023 Dec; 22(1):200. PubMed ID: 38066564
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The role of cryopreservation techniques in manufacturing, transport, and storage of Car-T therapy products.
    Jandova M; Stacey GN; Lanska M; Gregor I; Rozsivalova P; Bekova L; Duchacova ZW; Belada D; Radocha J; Mericka P; Fuller B
    Cryo Letters; 2023; 44(3):123-133. PubMed ID: 37883165
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. BloodChIP Xtra: an expanded database of comparative genome-wide transcription factor binding and gene-expression profiles in healthy human stem/progenitor subsets and leukemic cells.
    Thoms JAI; Koch FC; Raei A; Subramanian S; Wong JWH; Vafaee F; Pimanda JE
    Nucleic Acids Res; 2024 Jan; 52(D1):D1131-D1137. PubMed ID: 37870453
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Translational development of a novel BAFF-R CAR-T therapy targeting B-cell lymphoid malignancies.
    Luo Y; Qie Y; Gadd ME; Manna A; Rivera-Valentin R; To T; Li S; Yassine F; Murthy HS; Dronca R; Kharfan-Dabaja MA; Qin H
    Cancer Immunol Immunother; 2023 Dec; 72(12):4031-4047. PubMed ID: 37814001
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Activation of STING by SAMHD1 Deficiency Promotes PANoptosis and Enhances Efficacy of PD-L1 Blockade in Diffuse Large B-cell lymphoma.
    Cai Y; Chen X; Lu T; Fang X; Ding M; Yu Z; Hu S; Liu J; Zhou X; Wang X
    Int J Biol Sci; 2023; 19(14):4627-4643. PubMed ID: 37781035
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Integrated genomic and single-cell transcriptomic analyses reveal clonal evolution and immune signature in donor cell leukemia after haploidentical allogeneic hematopoietic stem cell transplantation.
    Chen H; Zhao X; Pan W; Xiao H
    Leuk Lymphoma; 2023 Oct; 64(10):1681-1688. PubMed ID: 37424322
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Ectopic expression of cGAS in
    Waanders L; van der Donk LEH; Ates LS; Maaskant J; van Hamme JL; Eldering E; van Bruggen JAC; Rietveld JM; Bitter W; Geijtenbeek TBH; Kuijl CP
    J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37072345
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. CRISPR/Cas9-Mediated Induction of Relapse-Specific
    Nguyen TTT; Tanaka Y; Sanada M; Hosaka M; Tamai M; Kagami K; Komatsu C; Somazu S; Harama D; Kasai S; Watanabe A; Akahane K; Goi K; Inukai T
    Mol Pharmacol; 2023 Apr; 103(4):199-210. PubMed ID: 36669880
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. CLIC-01: Manufacture and distribution of non-cryopreserved CAR-T cells for patients with CD19 positive hematologic malignancies.
    Kekre N; Hay KA; Webb JR; Mallick R; Balasundaram M; Sigrist MK; Clement AM; Nielsen JS; Quizi J; Yung E; Brown SD; Dreolini L; Waller DD; Smazynski J; Gierc NS; Loveless BC; Clark K; Dyer T; Hogg R; McCormick L; Gignac M; Bell S; Chapman DM; Bond D; Yong S; Fung R; Lockyer HM; Hodgson V; Murphy C; Subramanian A; Wiebe E; Yoganathan P; Medynski L; Vaillan DC; Black A; McDiarmid S; Kennah M; Hamelin L; Song K; Narayanan S; Rodrigo JA; Dupont S; Hawrysh T; Presseau J; Thavorn K; Lalu MM; Fergusson DA; Bell JC; Atkins H; Nelson BH; Holt RA
    Front Immunol; 2022; 13():1074740. PubMed ID: 36601119
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Integrating RNA-seq and scRNA-seq to explore the biological significance of NAD + metabolism-related genes in the initial diagnosis and relapse of childhood B-cell acute lymphoblastic leukemia.
    Lin C; Xu JQ; Zhong GC; Chen H; Xue HM; Yang M; Chen C
    Front Immunol; 2022; 13():1043111. PubMed ID: 36439178
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Pharmacologic Inhibition of nt5c2 Reverses Genetic and Nongenetic Drivers of 6-MP Resistance in Acute Lymphoblastic Leukemia.
    Reglero C; Dieck CL; Zask A; Forouhar F; Laurent AP; Lin WW; Albero R; Miller HI; Ma C; Gastier-Foster JM; Loh ML; Tong L; Stockwell BR; Palomero T; Ferrando AA
    Cancer Discov; 2022 Nov; 12(11):2646-2665. PubMed ID: 35984649
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Pediatric T-ALL type-1 and type-2 relapses develop along distinct pathways of clonal evolution.
    Richter-Pechańska P; Kunz JB; Rausch T; Erarslan-Uysal B; Bornhauser B; Frismantas V; Assenov Y; Zimmermann M; Happich M; von Knebel-Doeberitz C; von Neuhoff N; Köhler R; Stanulla M; Schrappe M; Cario G; Escherich G; Kirschner-Schwabe R; Eckert C; Avigad S; Pfister SM; Muckenthaler MU; Bourquin JP; Korbel JO; Kulozik AE
    Leukemia; 2022 Jul; 36(7):1759-1768. PubMed ID: 35585141
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Scaling up and scaling out: Advances and challenges in manufacturing engineered T cell therapies.
    Song HW; Somerville RP; Stroncek DF; Highfill SL
    Int Rev Immunol; 2022; 41(6):638-648. PubMed ID: 35486592
    [TBL] [Abstract] [Full Text] [Related]  

  • 15.
    Giesen D; Hooge MNL; Nijland M; Heyerdahl H; Dahle J; de Vries EGE; Pool M
    Sci Rep; 2022 Apr; 12(1):6286. PubMed ID: 35428777
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Droplet digital PCR allows vector copy number assessment and monitoring of experimental CAR T cells in murine xenograft models or approved CD19 CAR T cell-treated patients.
    Haderbache R; Warda W; Hervouet E; da Rocha MN; Trad R; Allain V; Nicod C; Thieblemeont C; Boissel N; Varlet P; Agha IY; Bouquet L; Guiot M; Venet F; Sujobert P; Roussel X; Rouzaire PO; Caillot D; Casasnovas O; Bories JC; Bachy E; Caillat-Zucman S; Deschamps M; Ferrand C
    J Transl Med; 2021 Jun; 19(1):265. PubMed ID: 34154602
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The genomic landscape of teenage and young adult T-cell acute lymphoblastic leukemia.
    Mansur MB; Furness CL; Nakjang S; Enshaei A; Alpar D; Colman SM; Minto L; Irving J; Poole BV; Noronha EP; Savola S; Iqbal S; Gribben J; Pombo-de-Oliveira MS; Ford TM; Greaves MF; van Delft FW
    Cancer Med; 2021 Jul; 10(14):4864-4873. PubMed ID: 34080325
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Primary disease sites and patterns of spread in cases of neurolymphomatosis in the orbit associated with lymphoma.
    Fritzhand SJ; Esmaeli B; Sun J; Debnam JM
    Cancer Imaging; 2021 May; 21(1):39. PubMed ID: 34039437
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Validation of an apoptosis assay for extracorporeal photopheresis.
    Hähnel V; Dormann F; Kronenberg K; Hutchinson JA; Burkhardt R; Ahrens N
    Transfus Med; 2021 Apr; 31(2):113-120. PubMed ID: 33665869
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Photochemotherapy Induces Interferon Type III Expression via STING Pathway.
    Biskup E; Larsen BD; Rib L; Folkersen L; Niazi O; Kamstrup MR; Sørensen CS
    Cells; 2020 Nov; 9(11):. PubMed ID: 33182724
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.